Subcutaneous fat hyperplasia
Conditions
Interventions
Test group:Treatment of subcutaneous fat hyperplasia caused by insulin using low-frequency ultrasound therapy device
Control group:On the basis of routine insulin injection health education (one injection, one inch at a time, i.e. no further insulin injection at the LH site, changing the injection site at least one
Sponsors
Shanghai Sixth People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients with diabetes who meet the diagnostic criteria of WHO in 1999, with insulin injection time = 6 months and subcutaneous fat hyperplasia; 2. Currently, insulin is still being used, and the insulin injection tools used are insulin injection pens and pen needles; 3. Age range from 18 to 75 years old, gender not limited; 4. I voluntarily participate in this trial.
Exclusion criteria
Exclusion criteria: 1. Acute complications such as ketoacidosis, non ketotic hyperosmolar coma, etc; 2. Patients with skin diseases such as lupus, psoriasis, or obvious skin defects/abnormalities (discoloration, tattoos, or other abnormalities) at the site of routine insulin injection, as well as patients with fresh or old abdominal wounds, surgical scars, or other conditions that may affect the results of this study; 3. Merge mental illnesses and uncooperative individuals; 4. Pregnant patients; 5. Patients with progressive malignant tumors or other serious wasting diseases, prone to concurrent infections and bleeding, and those with gastrointestinal organic lesions indicated by endoscopic examination.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the range and skin properties of subcutaneous fat hyperplasia sites on ultrasound imaging; | — |
Countries
China
Contacts
Public ContactRonghui Du
Shanghai Sixth People's Hospital
Outcome results
None listed